April 10, 2025 – TheNewswire -Toronto, Ontario –Helix BioPharma Corp. (HBP:CA)(TSX:“HBP”, OTC PINK:“HBPCD”, FRANKFURT:“HBP0”) (“Helix”or the ...
SAN MATEO, Calif.--(BUSINESS WIRE)--Helix, a leading population genomics company and provider of precision medicine genomics solutions, today announced a groundbreaking multi-year agreement with ...
SAN MATEO, Calif., Jan. 7, 2026 /PRNewswire/ -- Helix, the leading enterprise genomics company, today announced a multi-year strategic collaboration with GSK, the global biopharma company. This ...
Helix GenoSphere™ cohorts consist of comprehensive Exome+ ® genomic and rich longitudinal clinical data, enhanced with third party medical, pharmacy, and mortality claims. Designed to accelerate Life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results